Temesgen Z, Feinberg J: Tipranavir: a new option for the treatment of drug-resistant HIV infection. Clin Infect Dis. Temesgen, Z.; Feinberg, J. (септембар 2007). „Tipranavir: A new option for the treatment of drug-resistant HIV infection”. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45 (6): 761—9. PMID17712762. doi:10.1086/520847.CS1 одржавање: Формат датума (веза). Epub 2007 Aug 7.
Luna B, Townsend MU: Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistance. Clin Ther. Luna, B.; Townsend, M. U. (новембар 2007). „Tipranavir: The first nonpeptidic protease inhibitor for the treatment of protease resistance”. Clinical Therapeutics. 29 (11): 2309—18. PMID18158073. doi:10.1016/j.clinthera.2007.11.007.CS1 одржавање: Формат датума (веза)
Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.
Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID11749573. doi:10.1021/ci000392t.
Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID11020286. doi:10.1021/jm000942e.
Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.
Temesgen Z, Feinberg J: Tipranavir: a new option for the treatment of drug-resistant HIV infection. Clin Infect Dis. Temesgen, Z.; Feinberg, J. (септембар 2007). „Tipranavir: A new option for the treatment of drug-resistant HIV infection”. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45 (6): 761—9. PMID17712762. doi:10.1086/520847.CS1 одржавање: Формат датума (веза). Epub 2007 Aug 7.
Luna B, Townsend MU: Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistance. Clin Ther. Luna, B.; Townsend, M. U. (новембар 2007). „Tipranavir: The first nonpeptidic protease inhibitor for the treatment of protease resistance”. Clinical Therapeutics. 29 (11): 2309—18. PMID18158073. doi:10.1016/j.clinthera.2007.11.007.CS1 одржавање: Формат датума (веза)
Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID11749573. doi:10.1021/ci000392t.
Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID11020286. doi:10.1021/jm000942e.